{"filing":{"accession_number":"0001213900-26-091749","cik":"0001282980","ticker":"DROR","company_name":"Dror Ortho-Design, Inc.","form":"8-K","filing_date":"2026-08-19","report_date":"2026-08-19","primary_document":"ea0302752-8k_dror.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1282980/000121390026091749/ea0302752-8k_dror.htm"},"events":[{"id":28597,"run_id":26166,"accession_number":"0001213900-26-091749","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The Company entered into a Securities Purchase Agreement on August 19, 2026, to sell $275,000 in principal amount of Debentures and conditional warrants in a private placement to accredited investors under Section 4(a)(2) and Regulation D exemptions. The Debentures automatically convert to Common Stock upon a future Public Offering, and the Warrants are exercisable for additional Common Stock, creating significant dilution contingent on future capital raising. This is a classic dilutive private placement raising cash through unregistered securities with conversion and warrant features that will dilute existing shareholders.","company_name":"Dror Ortho-Design, Inc.","ticker":"DROR","filing_date":"2026-08-19","form":"8-K","submitted_at":null,"items":[{"id":30593,"accession_number":"0001213900-26-091749","item_number":"1.01","item_title":"Entry into a Material","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The Company entered into a Securities Purchase Agreement on August 19, 2026, to sell $275,000 in principal amount of Debentures and conditional warrants in a private placement to accredited investors under Section 4(a)(2) and Regulation D exemptions. The Debentures automatically convert to Common Stock upon a future Public Offering, and the Warrants are exercisable for additional Common Stock, creating significant dilution contingent on future capital raising. This is a classic dilutive private placement raising cash through unregistered securities with conversion and warrant features that will dilute existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:05:04.093421+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30593,"accession_number":"0001213900-26-091749","item_number":"1.01","item_title":"Entry into a Material","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The Company entered into a Securities Purchase Agreement on August 19, 2026, to sell $275,000 in principal amount of Debentures and conditional warrants in a private placement to accredited investors under Section 4(a)(2) and Regulation D exemptions. The Debentures automatically convert to Common Stock upon a future Public Offering, and the Warrants are exercisable for additional Common Stock, creating significant dilution contingent on future capital raising. This is a classic dilutive private placement raising cash through unregistered securities with conversion and warrant features that will dilute existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:05:04.093421+00:00","company_name":"Dror Ortho-Design, Inc.","ticker":"DROR","filing_date":"2026-08-19"}]}